Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04-2021) trial.

Olivier BylickiFlorian GuisierArnaud ScherpereelCatherine DanielAurélie SwalduzEmmanuel GrolleauMarie BernardiStephane HominalJean Briac PrevostGuillaume PamartMarie Héléne MarquesNicolas CloarecSimon DeshayesJudith RaimbourgRémi VeillonYoussef OulkhouirClarisse Audigier ValetteFabien SubtilChristos ChouaïdLaurent Greilliernull null

Published in: Lung cancer (Amsterdam, Netherlands) (2024)

For this unselected PM population, efficacy and safety outcomes compared favorably with CheckMate 743 trial results.

Keyphrases

phase iii
study protocol
phase ii
clinical trial
particulate matter
air pollution
randomized controlled trial
heavy metals
open label
locally advanced
squamous cell carcinoma
radiation therapy
skeletal muscle
water soluble